Advances in Hematology / 2019 / Article / Fig 1

Research Article

Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France

Figure 1

Second- and third-line treatment regimens. Note: regimen compositions listed are irrespective of concomitant dexamethasone use.
(a) Second-line treatment (n = 192)
(b) Third-line treatment (n = 114)